Reaction

Endometrial Adenocarcinoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 625 reports · 4 co-occurring drugs

As of the last recalculation, Endometrial Adenocarcinoma appears in 625 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is TESTOSTERONE (PRR 41.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Testosterone2841.741.8
Everolimus Tablets1632.632.6
Testosterone Cypionate518.818.8
Levonorgestrel386.66.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.